slides · global inventory
Traction
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,471
Current window 5,221-5,250
Pages 350
Rows per page 30
Slide type
5,221-5,250 of 10,471
21
Includes specific clinical trial safety metrics and footnotes regarding data definitions.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
27
The chart displays 'Maximum % Change from Baseline in Sum of Target Lesions'.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations 1 hit
29
The chart is a 'spider plot' or 'swimmer plot' variant showing % change in target lesions over time for two specific patients.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations 1 hit
31
The slide presents clinical data points (PR/CR rates) to justify moving to Phase 2.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations 1 hit
10
The slide uses a stacked bar chart to show membership growth and a grid of big-number metrics to characterize the patient population.Cano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations 1 hit
11
The slide uses a comparative bar chart structure to highlight performance improvements.Cano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations 1 hit
16
The slide uses a combination of a bar chart and a supporting data table to demonstrate the 'J-curve' of medical center profitability.Cano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
20
The slide uses a three-column layout to compare historical performance with future guidance.Cano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
46
The chart highlights a significant reduction in hospital utilization, a key performance metric for value-based care providers.Cano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations 1 hit
07
Data presented includes ORR, DOR, time to response, disease control rate, PFS, and overall survival metrics.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
09
The slide highlights clinical response rates (20-26%) and disease control rates (40-42%) using rigorous BICR methodology.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
10
The chart is a waterfall plot (often called a swimmer plot or spider plot in oncology, but specifically a waterfall plot here).Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
11
The slide uses a waterfall plot to visualize tumor shrinkage (Best % Change in SPD) across different patient performance status cohorts.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
12
The chart is a 'spider plot' or 'swimmer plot' variant showing % change in tumor size over time.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
14
Data table comparing All patients vs RANO HGG Responders vs RANO HGG and/or LGG Responders across survival and clinical metrics.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
24
Clinical trial data (NCT03034200) presented at ASCO 2021.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
31
The slide uses a human body diagram to categorize tumor types and presents preclinical data for each.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
33
The slide highlights early clinical efficacy data from a dose escalation trial.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations 1 hit
03
The slide highlights operational efficiency and growth progress.Cipher Mining | Investor Presentation Deck | 18 slides · Cipher Mining
Pitch deck Investor relations Beat · Traction1 hit
04
Cipher Mining | Investor Presentation Deck | 18 slidesCipher Mining | Investor Presentation Deck | 18 slides · Cipher Mining
Pitch deck Investor relations Beat · Traction1 hit
07
The slide combines operational status updates with a growth trajectory chart.Cipher Mining | Investor Presentation Deck | 18 slides · Cipher Mining
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
08
The slide presents four primary KPIs for a specific mining site, supported by aerial photography.Cipher Mining | Investor Presentation Deck | 18 slides · Cipher Mining
Pitch deck Investor relations Beat · Traction1 hit
09
Includes site photos and detailed footnotes regarding joint venture ownership and cost calculations.Cipher Mining | Investor Presentation Deck | 18 slides · Cipher Mining
Pitch deck Investor relations Beat · Traction1 hit
10
Includes facility photo and a timeline of hashrate deployment.Cipher Mining | Investor Presentation Deck | 18 slides · Cipher Mining
Pitch deck Investor relations Beat · Traction1 hit
11
The chart illustrates a specific 24-hour period where energy prices spiked, showing the difference between mining revenue and energy costs.Cipher Mining | Investor Presentation Deck | 18 slides · Cipher Mining
Pitch deck Investor relations 1 hit
09
Clinical trial data summary for CTX-009.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Hypothesis Test1 hit
10
The chart displays individual patient responses categorized by cancer type (Gastric, CRC, Other) and dosage (mpk).Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Hypothesis Test1 hit
11
The table highlights Partial Response rates with a red border.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Hypothesis Test1 hit
12
The chart uses a standard waterfall plot to visualize clinical efficacy (tumor shrinkage).Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Hypothesis Test1 hit
14
Compass Therapeutics | Investor Presentation Deck | 40 slidesCompass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Hypothesis Test1 hit